Pfizer's (PFE.US) $43 billion Seagen (SGEN.US) deal wins unconditional EU approval. As it was concluded by European lawmakers, deal wouldn't raise competition concerns or higher prices for oncology drugs.
Source: xStation5
Apple shares fall amid WWDC conference 📉 No AI breakthrough?
The World Cup on the Market: Is There an Opportunity for Profit?
Intel gains 10% after talks with Google and Nvidia
US Open: Nasdaq rebounds as oil price falls 📈 Intel and Corning shares surge